DexCom (DXCM) Tops Q1 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Dexcom Reports First Quarter 2019 Financial Results
May 1, 2019 4:02 PM EDTSAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March31, 2019.
First Quarter 2019 Highlights:
Revenue grew 52% versus the same quarter of the prior year to $280.5 million U.S. revenue growth of 45% and international revenue growth of 79% Demonstrated additional real-world clinical benefits driven by Dexcom real-time CGM, as described in recent scientific publications: Actionable, predictive low glucose alerts with the Dexcom G6 enable further reductions in hypoglycemia, independent of... More